Pseudotropine

Pseudotropine

SCHEMBL7296808

CN1C2CCC1CC(O)C2.[LiH]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.94
CYP2C9 P11712 1/20 0.94
CHRM3 P20309 6/20 0.41
CHRM2 P08172 4/20 0.41
CHRM1 P11229 4/20 0.41
TDP1 Q9NUW8 1/20 0.39
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
OPRL1 P41146 1/20 0.36
HTR3E A5X5Y0 2/20 0.35
HTR3B O95264 2/20 0.35
HTR3A P46098 2/20 0.35
HTR3D Q70Z44 2/20 0.35
HTR3C Q8WXA8 2/20 0.35
CHRNA7 P36544 1/20 0.35
CHRM4 P08173 2/20 0.34
CHRM5 P08912 1/20 0.34
ADRA2A P08913 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pseudotropine SCHEMBL7296801 1.00 LMNA (0.94) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL64824 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL21563309 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL100196 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL31078606 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL2442824 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL745726 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL6944859 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL38978 0.97 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL228981 0.94 LMNA (0.94) LMNACYP2C9CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102367251-B More stable tropisetron compound and pharmaceutical composition thereof JINFENG HE 2012-11-07 CN disclosed
CN-102584815-A Method for preparing tropisetron hydrochloride on large scale HUNAN KAMP INST FOR MEDICAL RES 2012-07-18 CN disclosed
CN-102367251-A More stable tropisetron compound and pharmaceutical composition thereof JINFENG HE 2012-03-07 CN disclosed
CN-100503601-C Process of preparing troipisetron BEIJING CHENGYU CHEMICAL INDUS (CN) 2009-06-24 CN disclosed
CN-101033225-A Process of preparing troipisetron BEIJING CHENGYU CHEMICAL INDUS (CN) 2007-09-12 CN disclosed
EP-0560604-B1 Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists MITSUBISHI CHEM CORP (JP) 1997-01-29 EP disclosed
US-5556851-A TREATMENT OF NAUSEA OR EMESIS FROM ANTICANCER DRUGS OR X-RAY TREATMENT MITSUBISHI CHEMICAL CORPORATION (JP) 1996-09-17 US disclosed
US-5391549-A Antagonistifc activity against serotonin 5HT3 receptors MITSUBISHI KASEI CORPORATION (JP) 1995-02-21 US disclosed
EP-0560604-A1 Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists Mitsubishi Chemical Corporation (JP) 1993-09-15 EP disclosed